Study on the potential way of hepatic cytotoxicity of N,N-dimethylformamide

Area of Science:

• Hepatotoxicity Research
• Cellular Toxicology
• Occupational Health

Background:

• N,N-dimethylformamide (DMF) is linked to hepatotoxicity, with intermediate metabolites and redox imbalance implicated.
• The precise mechanism of DMF-induced liver injury remains unclear.
• Investigating the role of specific pathways in DMF toxicity is crucial for understanding its effects.

Purpose of the Study:

• To elucidate the mechanism of N,N-dimethylformamide (DMF)-induced hepatotoxicity in HL7702 cells.
• To determine the relative contributions of reactive oxygen species (ROS) and metabolite biodegradation to DMF toxicity.
• To identify potential preventative strategies for occupational exposure to DMF.

Main Methods:

• Utilized HL7702 cells exposed to N,N-dimethylformamide (DMF).
• Employed catalase to inhibit reactive oxygen species (ROS) production.
• Used a CYP2E1 antagonist (DDC) to reduce DMF biodegradation.
• Assessed cell apoptosis, mitochondrial transmembrane potential (MMP), and key apoptotic proteins (Bax, Bcl-xl, cleaved-caspase 9).

Main Results:

• DMF induced apoptosis via mitochondrial and p53 pathways.
• Catalase significantly attenuated apoptosis, mitochondrial damage, and apoptotic markers by inhibiting ROS.
• DDC partially reduced late apoptosis, affecting the p53 pathway but not significantly altering mitochondrial parameters.
• Restoring redox balance proved more effective than reducing DMF metabolism in mitigating toxicity.

Conclusions:

• Reactive oxygen species (ROS) play a critical role in N,N-dimethylformamide (DMF)-induced hepatotoxicity, primarily through mitochondrial pathways.
• While DMF biodegradation contributes to toxicity, managing redox balance is a more effective intervention.
• Findings suggest that maintaining redox homeostasis could be a key strategy for preventing occupational liver injury from DMF exposure.